Patricia
Miranda Azpiazu
Chercheuse jusqu' 2024
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, EspañaPublications en collaboration avec des chercheurs de Instituto de Investigación Sanitaria Biobizkaia (7)
2024
-
Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects
Translational Psychiatry, Vol. 14, Núm. 1
2021
-
Correction to: Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation (Pharmacological Reports, (2021), 73, 4, (1079-1095), 10.1007/s43440-021-00253-z)
Pharmacological Reports
-
Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment
Translational Psychiatry, Vol. 11, Núm. 1
-
Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation
Pharmacological Reports, Vol. 73, Núm. 4, pp. 1079-1095
2019
-
Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins
European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1453-1463
2016
-
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia
Science Signaling, Vol. 9, Núm. 410
2014
-
Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment
Neuropharmacology, Vol. 86, pp. 311-318